According to visionary Sebastian Brunemeier, only recently have we been able to understand the "fundamental molecular and cellular biology of the aging process.”
Newfound technologies have allowed scientists to extend the healthy lifespan of mice by up to 30%, and he believes this research can, and will, eventually be applied to slow the aging process for humans as well.
But how big is the market around longevity biotech? Since welcoming early investors like Peter Thiel and Bob Nelson, Brunemeier says there’s “a huge industry building around longevity biotech” and reveals the potential for economic change searching for the elixir of life. Recorded on February 18, 2022.
🌎 Global Recession: Is Everyone Wrong?
14 Days. 10+ Experts. All angles. Join 290,000+ people around the world who watch Real Vision to figure out where it’s all headed (and what it means for you).
👉 Get 14 days of Real Vision for $1 [ Ссылка ]
Thanks for watching Real Visionaries on Real Vision Finance!
#longevity #biopharma #biotech
✅ Subscribe to our channel now for more videos like this one: [ Ссылка ]
About Real Vision™:
Real Vision™ is where you can gain an understanding of the complex world of finance, business, and the global economy with real in-depth analysis from real experts.
Connect with Real Vision™ Online:
Real Vision Crypto: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
Linkedin: [ Ссылка ]
#recession #RaoulPal #Macro #finance #macroeconomy #stagflation #marketcrash #markets #financialmarkets #bonds #stocks #oil #gas #energy #commodities #equities #gold #crypto #cryptocurrency
Disclaimer:
This is pretty obvious, but we should probably say it anyway so that there is absolutely no confusion…The material in REAL VISION GROUP video programs and publications {collectively referred to as “RV RELEASES”} is provided for informational purposes only and is NOT investment advice. The information in RV RELEASES has been obtained from sources believed to be reliable, but Real Vision and its contributors, distributors and/or publisher, licensors, and their respective employees, contractors, agents, suppliers, and vendors { collectively, “Affiliated Parties”} make no representation or warranty as to the accuracy, timeliness or completeness of the content in RV RELEASES. Any data included in RV RELEASES are illustrative only and not for investment purposes. Any opinion or recommendation expressed in RV RELEASES is subject to change without notice. RV Releases do not recommend, explicitly nor implicitly, nor suggest or recommend any investment strategy. Real Vision Group and its Affiliated Parties disclaim all liability for any loss that may arise (whether direct indirect, consequential, incidental, punitive or otherwise) from any use of the information in RV RELEASES. Real Vision Group and its Affiliated Parties do not have regard for any individual’s, group of individuals’ or entity’s specific investment objectives, financial situation, or circumstance. RV RELEASES do not express any opinion on the future value of any security, currency, or other investment instruments. You should seek expert financial and other advice regarding the appropriateness of the material discussed or recommended in RV RELEASES and should note that investment values may fall, you may receive less back than originally invested and past performances are not necessarily reflective of future performances. Well, that was pretty intense! We hope you got all of that – now stop reading the small print and go and enjoy Real Vision.
